Psychopharmacotherapy of bipolar affective disorders;Psychopharmakotherapie bipolarer affektiver Erkrankungen

Nervenarzt

Volumn 73, Issue 1, 2002, Pages 4-19

  Grunze, H ^a,j   Walden, J ^b   Dittmann, S ^a   Berger, M ^b   Bergmann, A ^c   Braunig P ^d   Dose, M ^c   Emrich, H M ^e   Gastpar, M ^f   Greil, W ^g   Kruger S ^h   Moller H J ^a   Uebelhack, R ⁱ  

^a UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c Neuburg/Donau ^*  (Germany)

^d Verhaltensmedizin Psychosomatik A   (Germany)

^e HANNOVER MEDICAL SCHOOL   (Germany)

^f UNIVERSITY HOSPITAL ESSEN   (Germany)

^g Psychiatrische Privatklinik Sanatorium Kilchberg   (Switzerland)

^h UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

ⁱ HUMBOLDT UNIVERSITY   (Germany)

^j LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

more..

Author keywords

Acute treatment; Anticonvulsants; Bipolar disorder; Continuation treatment; Lithium; Maintenance treatment; Manic depressive illness

Indexed keywords

AMFEBUTAMONE; AMISULPRIDE; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; BENZODIAZEPINE; CALCIUM CHANNEL BLOCKING AGENT; CARBAMAZEPINE; CHLORPROMAZINE; CLONAZEPAM; CLOZAPINE; HALOPERIDOL; LAMOTRIGINE; LITHIUM; LORAZEPAM; MIRTAZAPINE; MOOD STABILIZER; NEUROLEPTIC AGENT; NIMODIPINE; OLANZAPINE; OXCARBAZEPINE; RISPERIDONE; SEDATIVE AGENT; SEROTONIN UPTAKE INHIBITOR; TETRACYCLIC ANTIDEPRESSANT AGENT; TRANQUILIZER; TRICYCLIC ANTIDEPRESSANT AGENT; VALPROIC ACID; VENLAFAXINE;

AKATHISIA; ARTICLE; BIPOLAR DISORDER; CLINICAL TRIAL; DEPRESSION; DEPRESSIVE PSYCHOSIS; DISEASE CLASSIFICATION; DYSKINESIA; EUPHORIA; EXTRAPYRAMIDAL SYMPTOM; HEMATOLOGIC DISEASE; HUMAN; HYPOMANIA; MANIA; PATIENT COMPLIANCE; PRACTICE GUIDELINE; PSYCHOPHARMACOTHERAPY; PSYCHOTHERAPY; SIDE EFFECT; SYMPTOMATOLOGY; CONSENSUS DEVELOPMENT; DRUG COMBINATION; PSYCHOLOGICAL ASPECT; REVIEW;

ANTIDEPRESSIVE AGENTS; ANTIMANIC AGENTS; BIPOLAR DISORDER; CONSENSUS DEVELOPMENT CONFERENCES; DRUG THERAPY, COMBINATION; HUMANS; PRACTICE GUIDELINES;

EID: 0036371717     PISSN: 00282804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s115-002-8142-7     Document Type: Article

References (82)

1. Abou-Saleh MT, Coppen A (1986) Who responds to prophylactic lithium? J Affect Disord 10: 115-125
2. Adli M, Bschor T, Canata B, Döpfmer S, Bauer M (1998) Lithium in der Behandlung der akuten Depression. Fortschr Neurol Psychiatr 66: 435-441
3. Akiskal HS, Hantouche EG, Bourgeois ML et al. (1998) Gender, temperament, and the clinical picture in dysphoric mixed mania: Findings from a French national study (EPIMAN). J Affect Disord 50: 175-186
4. Altshuler LL, Post RM, Leverich GS, Mikalauskas K, Rosoff A, Ackerman L (1995) Antidepressant-induced mania and cycle acceleration: a controversy revisited. Am J Psychiatry 152: 1130-1138
5. American Psychiatric Association (1994) Practice guideline for the treatment of patients with bipolar disorder. Am Psychiatr Assoc. Am J Psychiatry 151: 1-36
6. American Psychiatric Association (1996) Diagnostisches und statistisches Manual psychischer Störungen DSM-IV. Hogrefe, Göttingen Bern Toronto Seattle
7. Angst J (1995) The epidemiology of depressive disorders. Eur Neuropsychopharmacol 5 [Suppl]: 95-98
8. Bauer M, Hellweg R, Baumgartner A (1998) Hochdosierte Thyroxinbehandlung bei therapie- und prophylaxeresistenten Patienten mit affektiven Psychosen. Nervenarzt 69: 1019-1022
9. Bauer m, Ströhle A (1999) Behandlungsstrategien bei prophylaxeresistenten bipolaren Störungen.Nervenarzt 70:587-599
10. Bauer M, Priebe S, Berghofer A, Bschor T, Kiesslinger U, Whybrow PC (2001) Subjective response to and tolerability of long-term supraphysiological doses of levothyroxine in refractory mood disorders. J Affect Disord 64: 35-42
11. Bottlender R, Rudolf D, Strauß A, Möller H-J (1998) Antidepressant-associated maniform states in acute treatment of patients with bipolar I depression. Eur Arch Psychiatry Clin Neurosci 248: 296-300
12. Bourgeois ML, Hantouche EG, Akiskal HS (1997) The Epiman and Epidep french studies of bipolarity. J Bipol Disord 1: 13-19
13. Bowden CL (2000) Efficacy of lithium in mania and maintenance therapy of bipolar disorder. J Clin Psychiatry 61 [Suppl 9]: 35-40
14. Bowden CL, Brugger AM, Swann AC et al. (1994) Efficacy of divalproex vs lithium and placebo in the treatment of mania. The Depakote Mania Study Group. JAMA 271: 918-924
15. Bowden CL, Calabrese JR, McElroy SL et al. (2000) A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group. Arch Gen Psychiatry 57: 481-489
16. Calabrese JR, Bowden CL, DeVeaugh-Geiss J, Earl NL (2001) Lamotrigine demonstrates long-term mood stabilization in manic patients. APA Annu Meet Abstr, NR 403
17. Calabrese JR, Bowden CL, Sachs GS, Ascher JA, Monaghan E, Rudd G. for the Lamictal 602 Study Group (1999) A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. J Clin Psychiatry 60: 79-88
18. Calabrese JR, Fatemi SH, Kujawa M, Woyshville MJ (1996) Predictors of response to mood stabilizers. J Clin Psychopharmacol 16: 24S-31S
19. Calabrese JR, Rapport DJ, Kimmel SE, Reece B, Woyshville MJ (1993) Rapid cycling bipolar disorder and its treatment with valproate. Can J Psychiatry 38: S57-S61
20. Calabrese JR, Woyshville MJ, Kimmel SE, Rapport DJ (1993) Predictors of valproate response in bipolar rapid cycling. J Clin Psychiatry 13: 280-283
21. Chang KD, Keck PE, Stanton SP, McElroy SL, Strakowski SM, Geracioti TD (1998) Differences in thyroid function between bipolar manic and mixed states. Biol Psychiatry 43: 730-733
22. Coccaro EF, Siever LJ, Klar HM et al. (1989) Serotonergic studies in patients with affective and personality disorders. Correlates with suicidal and impulsive aggressive behavior. Arch Gen Psychiatry 46: 587-599
23. Emrich HM, Dose M, von Zerssen D (1985) The use of sodium valproate, carbamazepine and oxcarbazepine in patients with affective disorders. J Affect Disord 8: 243-250
24. Folkerts H, Bender S, Erkwoh R, Klieser E, Klimke A (1996) Entwurf von DGPPN-Leitlinien zur Indikation und Durchführung der Elektrokrampftherapie (EKT). Nervenarzt 67: 509-514
25. Frances A, Docherty JP, Kahn DA (1996) The Expert Consensus Guideline Series. Treatment of bipolar disorder. J Clin Psychiatry 57 [Suppl 12a]: 3-88
26. Freeman MP, Stoll AL (1998) Mood stabilizer combinations: a review of safety and efficacy. Am J Psychiatry 155: 12-21
27. Freeman TW, Clothier JL, Pazzaglia P, Lesem MD, Swann AC (1992) A double-blind comparison of valproate and lithium in the treatment of acute mania. Am J Psychiatry 149: 108-111
28. Frye MA, Ketter TA, Altshuler LL et al. (1998) Clozapine in bipolar disorder: treatment implications for other atypical antipsychotics. J Affect Disord 48: 91-104
29. Gardner DL, Cowdry RW (1986) Positive effects of carbamazepineon behavioral dyscontrol in borderline personality disorder. Am J Psychiatry 143: 519-522
30. Goncalves N, Stoll KD (1985) Carbamazepin bei manischen Syndromen. Eine kontrollierte Doppelblind-Studie. Nervenarzt 56: 43-47
31. Goodwin FK, Ghaemi SN (1998) Understanding manic-depressive illness. Arch Gen Psychiatry 55: 23-25
32. Goodwin FK, Jamison KR (1990) Manic-depressive illness. Oxford Univ Press, New York
33. Greil W, Kleindienst N, Erazo N, Müller-Oerlinghausen B (1998) Differential response to lithium and carbamazepine in the prophylaxis of bipolar disorder. J Clin Psychopharmacol 18: 455-460
34. Greil W, Ludwig-Mayerhofer W, Erazo N et al. (1997) Lithium vs carbamazepine in the maintenance treatment of schizoaffective disorder: a randomised study. Eur Arch Psychiatry Clin Neurosci 247: 42-50
35. Greil W, Sassim N, Ströbel-Sassim C (1996) Die manisch-depressive Krankheit: Therapie mit Carbamazepin. Thieme, Stuttgart
36. Grunze H, Erfurth A, Schäfer M, Amann B, Meyendorf R (1999) Elektrokonvulsionstherapie in der Behandlung der schweren Manie. Nervenarzt 70: 662-667
37. Grunze H, Schlösser S, Walden J (1999) Neue Perspektiven in der Akutbehandlung bipolarer Depressionen. PTT 6: 53-59
38. Harrow M, Yonan CA, Sands JR, Marengo J (1994) Depression in schizophrenia: are neuroleptics, akinesia, or anhedonia involved? Schizophr Bull 20: 327-338
39. Hesslinger B, Normann C, Langosch JM, Klose P, Berger M, Walden J (1999) Effects of carbamazepine and valproate on haloperidol plasma levels and on psychopathologic outcome in schizophrenic patients. J Clin Psychopharmacol 19: 310-315
40. Keck PE, McElroy SL (1996) Outcome in the pharmacologic treatment of bipolar disorder. J Clin Psychopharmacol 16: 15S-23S
41. Keck PE, McElroy SL, Strakowski SM, Soutullo CA (2000) Antipsychotics in the treatment of mood disorders and risk of tardive dyskinesia. J Clin Psychiatry 61: 33-38
42. Keller MB, Lavori PW, Coryell W, Endicott J, Mueller TI (1993) Bipolar I: a five-year prospective follow-up. J Nerv Ment Dis 181: 238-245
43. Kusalic M, Engelsmann F (1999) Effect of lithium maintenance therapy on thyroid and parathyroid function. J Psychiatry Neurosci 24: 227-233
44. Kusumakar V, Yatham LN, Haslam DR, Parikh SV, Matte R, Silverstone PH, Sharma V (1997) Treatment of mania, mixed state, and rapid cycling. Can J Psychiatry 42 [Suppl 2]: 79-86
45. Kusumi I, Ohmori T, Kohsaka M, Ito M, Honma H, Koyama T (1995) Chronobiological approach for treatment-resistant rapid cycling affective disorders. Biol Psychiatry 37: 553-559
46. Lenox RH, Newhouse PA, Creelman WL, Whitaker TM (1992) Adjunctive treatment of manic agitation with lorazepam versus haloperidol: a double-blind study. J Clin Psychiatry 53: 47-52
47. Lewis JL, Winokur G (1982) The induction of mania. A natural history study with controls. Arch Gen Psychiatry 39: 303-306
48. Lusznat RM, Murphy DP, Nunn CM (1988) Carbamazepine vs lithium in the treatment and prophylaxis of mania. Br J Psychiatry 153: 198-204
49. Maj M (1990) Clinical prediction of response to lithium prophylaxis in bipolar patients: the importance of the previous pattern of course of the illness. Clin Neuropharmacol 13 [Suppl 1]: S66-S70
50. Mann JJ, Arango V (1992) Integration of neurobiology and psychopathology in a unified model of suicidal behavior. J Clin Psychopharmacol 12: 2S-7S
51. McElroy SL, Keck PE, Stanton SP, Tugrul KC, Bennett JA, Strakowski SM (1996) A randomized comparison of divalproex oral loading versus haloperidol in the initial treatment of acute psychotic mania. J Clin Psychiatry 57: 142-146
52. Moleman P, Hartong EGTM, Hoogduin CAL, Broekman TG, Nolen W (2000) Lithium and carbamazepine in bipolar disorder. Acta Neuropsychiatrica 12: 120-121
53. Möller H-J, Bottlender R, Grunze H, Strauß A, Wittmann J (2001) Are antidepressants not or less effective in the acute treatment of bipolar compared to unipolar depression? J Affect Disord (im Druck)
54. Möller H-J, Grunze H (2000) Have some guidelines for the treatment of acute bipolar depression gone too far in the restriction of antidepressants? Eur Arch Psychiatry Clin Neurosci 250: 57-68
55. Müller-Oerlinghausen B, Retzow A, Henn F, Giedke H, Walden J (2000) Valproate as an adjunct to neuroleptic medication for the treatment of acute episodes of mania. A prospective, randomized, double- blind, placebo-controlled multicenter study. J Clin Psychopharmacol 20: 195-203
56. Nolen W, Knoppert-van der Klein EAM, Bouvy PF, Honig A, Klompenhouwer J-L, Ravelli DP (1998) Richtlijn farmacotherapie bipolaire stoornissen. Boom, Amsterdam
57. Okuma T (1993) Effects of carbamazepine and lithium on affective disorders. Neuropsychobiology 27: 138-145
58. Okuma T, Kishimoto A, Inoue K, Matsumoto H, Ogura A (1973) Anti-manic and prophylactic effects of carbamazepine (Tegretol) on manic depressive psychosis. A preliminary report. Folia Psychiatr Neurol Jpn 27: 283-297
59. Okuma T, Yamashita I, Takahashi R et al. (1990) Comparison of the anti manic efficacy of carbamazepine and lithium carbonate by double-blind controlled study. Pharmacopsychiatry 23: 143-150
60. Pazzaglia P, Post RM, Ketter TA et al. (1998) Nimodipine monotherapy and carbamazepine augmentation in patients with refractory recurrent affective illness. J Clin Psychopharmacol 18: 404-413
61. Peet M (1994) Induction of mania with selective serotonin re-uptake inhibitors and tricyclic antidepressants. Br J Psychiatry 164: 549-550
62. Perry PJ (1996) Pharmacotherapy for major depression with melancholic features: Relative efficacy of tricyclic versus selective serotonin reuptake inhibitor antidepressants. J Affect Disord 39: 1-6
63. Pope HG, McElroy SL, Keck-PE J, Hudson JI (1991) Valproate in the treatment of acute mania. A placebo-controlled study. Arch Gen Psychiatry 48: 62-68
64. Post RM, Ketter TA, Denicoff K et al. (1996) The place of anticonvulsant therapy in bipolar illness. Psychopharmacology 128: 115-129
65. Prien RF, Klett CJ, Caffey-EM J (1974) Lithium prophylaxis in recurrent affective illness. Am J Psychiatry 131: 198-203
66. Sachs G, Ghaemi, SN (2000) Efficacy and tolerability of risperidone versus placebo in combination with lithium or valproate in acute mania. European Neuropsychopharmacology 10 [Supp 3]: 240
67. Sachs GS (1996) Bipolar mood disorder: practical strategies for acute and maintenance phase treatment. J Clin Psychopharmacol 16: 32-47
68. Sachs GS, Lafer B, Stoll AL, Banov M, Thibault AB, Tohen M, Rosenbaum JE (1994) A double-blind trial of bupropion versus desipramine for bipolar depression. J Clin Psychiatry 55: 391-393
69. Solomon DA, Keitner GI, Ryan CE, Miller IW (1998) Lithium plus valproate as maintenance polypharmacy for patients with bipolar I disorder: a review. J Clin Psychopharmacol 18: 38-49
70. Suppes T, McElroy SL, Gilbert J, Dessain EC, Cole JO (1992) Clozapine in the treatment of dysphoric mania. Biol Psychiatry 32: 270-280
71. Swann AC, Bowden CL, Morris D et al. (1997) Depression during mania. Treatment response to lithium or divalproex. Arch Gen Psychiatry 54: 37-42
72. Tohen M, Jacobs TG, Grundy SL et al. (2000) Efficacy of olanzapine in acute bipolar mania: A double-blind, placebo-controlled study. Arch Gen Psychiatry 57: 841-849
73. Tohen M, Sanger TM, McElroy SL et al. (1999) Olanzapine versus placebo in the treatment of acute mania. Am J Psychiatry 156: 702-709
74. Tohen M, Zarate CA, Centorrino F, Hegarty JI, Froeschl M, Zarate SB (1996) Risperidone in the treatment of mania. J Clin Psychiatry 57: 249-253
75. Tondo L, Baldessarini RJ (1998) Rapid cycling in women and men with bipolar manic-depressive disorders. Am J Psychiatry 155: 1434-1436
76. Tondo L, Laddomada P, Serra G, Minnai G, Kukopulos A (1981) Rapid cyclers and antidepressants. Int Pharmacopsychiatry 16: 119-123
77. van Calker D, Berger M (2000) Affektive Erkrankungen. Richtlinienentwurf der DGPPN. Steinkopff, Darmstadt
78. Vieta E, Martínez-Arán A, Colom F, Benabarre A, Reinares M, Gastó C (2000) Treatment of bipolar depression: paroxetine vs. venlafaxine. Int J Neuropsychopharmacol 3 [Suppl 1]: 336-337
79. Walden J, Grunze H, Schlösser S et al. (1999) Empfehlungen für die Behandlung bipolarer effektiver Störungen. PPT 6: 115-123
80. Walden J, Normann C, Langosch JM, Berger M, Grunze H (1998) Differential treatment of bipolar disorder with old and new antiepileptic drugs. Neuropsychobiology 38: 181-184
81. Walden J, Schaerer LO, Schlösser S, Grunze H (2000) An open longitidinal study of patients with bipolar rapid cycling treated with lithium or lamotrigine for mood stabilzation. Bipol Disord 2: 336-339
82. Young RC, Nysewander RW, Schreiber MT (1982) Mania ratings at discharge from hospital: a follow-up. J Nerv Ment Dis 170: 638-639